Key points from article :
Deep Longevity has entered into a partnership with Longenesis, a company focused on consent-enabled safe data curation for research.
Collaboration will integrate Longenesis’ consent management system into the Deep Longevity digital platform (including Young.AI).
The companies will also be developing a federated learning framework together.
"... will allow us to train multiple new aging clocks without the need to transfer user data,” - Polina Mamoshina, Deep Longevity CSO.
"...centralized, compliant and seamless biomedical data asset identification is crucial" - Sergey Jakimov, Longenesis CEO.
There is a need for a common standard for data management of client/patient data in the longevity field.
